Concatenated Multitype L2 Fusion Proteins as Candidate Prophylactic Pan-Human Papillomavirus Vaccines

BACKGROUND: Vaccination with minor capsid protein L2 induces antibodies that cross-neutralize diverse papillomavirus types. However, neutralizing antibody titers against the papillomavirus type from which the L2 vaccine was derived are generally higher than the titers against heterologous types, whi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jagu, Subhashini, Karanam, Balasubramanyam, Gambhira, Ratish, Chivukula, Sudha V., Chaganti, Revathi J., Lowy, Douglas R., Schiller, John T., Roden, Richard B. S.
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2009
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689872/
https://www.ncbi.nlm.nih.gov/pubmed/19470949
http://dx.doi.org/10.1093/jnci/djp106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689872/
https://www.ncbi.nlm.nih.gov/pubmed/19470949
http://dx.doi.org/10.1093/jnci/djp106

Ejemplares similares